Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Invesco WilderHill Clean Energy ETF
PBW
$458M
| $15.3K | ﹤0.01% |
770
| – | – |
|
4727
Identive
INVE
$61.2M
| $15.2K | ﹤0.01% |
4,662
| – | – |
|
4728
Mitsubishi UFJ Financial
MUFG
$251B
| $15K | ﹤0.01% |
1,090
-707
| -39% | -$9.14K |
|
4729
Pliant Therapeutics
PLRX
$64.4M
| $14.9K | ﹤0.01% |
12,886
-59,026
| -82% | -$83.4K |
|
4730
McEwen Inc
MUX
$1.18B
| $14.9K | ﹤0.01% |
1,554
-1,634
| -51% | -$13.3K |
|
4731
Cabaletta Bio
CABA
$457M
| $14.8K | ﹤0.01% |
9,737
-46,701
| -83% | -$72.8K |
|
4732
Saga Communications
SGA
$61.4M
| $14.7K | ﹤0.01% |
1,129
| – | – |
|
4733
Veritone
VERI
$134M
| $14.5K | ﹤0.01% |
11,535
-7,138
| -38% | -$13K |
|
4734
America Movil
AMX
$71.7B
| $14.5K | ﹤0.01% |
806
-942
| -54% | -$15.7K |
|
4735
Werewolf Therapeutics
HOWL
$18.6M
| $14.4K | ﹤0.01% |
13,236
-32,125
| -71% | -$33.1K |
|
4736
GrowGeneration
GRWG
$85.9M
| $14.4K | ﹤0.01% |
15,380
-41,043
| -73% | -$43.8K |
|
4737
Leslie's
LESL
$10.4M
| $14.3K | ﹤0.01% |
1,706
-16,859
| -91% | -$222K |
|
4738
StealthGas
GASS
$328M
| $13.9K | ﹤0.01% |
+2,169
| New | +$12.4K |
|
4739
Diageo
DEO
$54B
| $13.8K | ﹤0.01% |
137
-96
| -41% | -$10.4K |
|
4740
Commercial Vehicle Group
CVGI
$134M
| $13.8K | ﹤0.01% |
8,299
-25,483
| -75% | -$31K |
|
4741
Wipro
WIT
$19.7B
| $13.7K | ﹤0.01% |
4,535
-24,931
| -85% | -$72.5K |
|
4742
Vanguard Health Care ETF
VHT
$19B
| $13.7K | ﹤0.01% |
55
| – | – |
|
4743
Codere Online
CDRO
$403M
| $13.6K | ﹤0.01% |
1,607
| – | – |
|
|
EXOD
4744
Exodus Movement Inc
EXOD
$156M
| $13.6K | ﹤0.01% |
+470
| New | +$17.2K |
|
|
PRT
4745
PermRock Royalty Trust Unit
PRT
$27.1M
| $13.5K | ﹤0.01% |
3,221
| – | – |
|
4746
Comscore
SCOR
$106M
| $13.5K | ﹤0.01% |
2,795
| – | – |
|
4747
First Trust Indxx Innovative Transaction & Process ETF
LEGR
$133M
| $13.5K | ﹤0.01% |
250
| – | – |
|
4748
Innovator US Equity Ultra Buffer ETF March
UMAR
$195M
| $13.3K | ﹤0.01% |
+353
| New | +$12.7K |
|
4749
Sensus Healthcare
SRTS
$50.9M
| $13K | ﹤0.01% |
2,738
+869
| +46% | +$4.07K |
|
4750
Vanguard Materials ETF
VAW
$3.1B
| $12.7K | ﹤0.01% |
65
| – | – |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.